1-3 of 3
Kathleen A. Donovan, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma.

Catherine A Taylor, John A. Lust, MD, PhD, Bin Ye, Zhongda Liu, Zhong Sun, Richard S. Dondero, PhD, Bruce Galton, Kathleen A. Donovan, Ph.D., John E. Thompson
Journal: Blood
Blood (2009) 114 (22): 2462.
https://doi.org/10.1182/blood.V114.22.2462.2462
Published: 2009
Journal Articles

IL-1 Antagonists Are More Effective at Inhibiting IL-6 Production Than Apoptosis Inducing Agents: Implications for Targeting the Myeloma Proliferative Component.

John A. Lust, MD, PhD, Steven R. Zeldenrust, M.D., Ph.D., Laurie L. Moon-Tasson, Kathleen A. Donovan, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1831.
https://doi.org/10.1182/blood.V114.22.1831.1831
Published: 2009
Journal Articles

Differential Cytokine and Chemokine Profiles from MGUS, SMM, and MM Patient Bone Marrow; Significance of Stromal Interaction and Correlation of IL-8 with the Progression of Myeloma.

Michael P. Kline, Ph.D., Kathleen A. Donovan, Ph.D., Laurie L. Moon-Tasson, Christopher E. Lust, Wendy Y. Jin, John A. Lust, M.D.Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3651.
https://doi.org/10.1182/blood.V104.11.3651.3651
Published: 2004